We are live on ! Find out more
AAM

Azzad Asset Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 38.47%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+38.47%
3 Year Est. Return
+100.53%
5 Year Est. Return
+132.43%
10 Year Est. Return
+597.52%
AUM
$744M
AUM Growth
+$43.5M
Cap. Flow
-$2.86M
Cap. Flow %
-0.38%
Top 10 Hldgs %
18.39%
Holding
331
New
14
Increased
204
Reduced
84
Closed
11

Top Buys

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$2.06M
2
PSA icon
Public Storage
PSA
+$1.77M
3
TGT icon
Target
TGT
+$1.56M
4
TSLA icon
Tesla
TSLA
+$1.39M
5
META icon
Meta Platforms (Facebook)
META
+$1.37M

Top Sells

Rank Stock Value
1
ABB
ABB Ltd
ABB
+$4.32M
2
ANET icon
Arista Networks
ANET
+$2.53M
3
DHR icon
Danaher
DHR
+$2.18M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$2.01M
5
O icon
Realty Income
O
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 29.27%
2 Healthcare 14.83%
3 Industrials 13.37%
4 Consumer Discretionary 10.68%
5 Consumer Staples 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLAB icon
301
Mesa Laboratories
MLAB
$564M
$288K 0.04%
2,241
+75
+3% +$11.4K
NIO icon
302
NIO
NIO
$12.2B
$286K 0.04%
29,471
-13,828
-32% -$117K
EGP icon
303
EastGroup Properties
EGP
$11.2B
$283K 0.04%
1,628
+57
+4% +$9.51K
SLB icon
304
SLB Ltd
SLB
$73.6B
$268K 0.04%
5,457
+76
+1% +$3.62K
FR icon
305
First Industrial Realty Trust
FR
$8.73B
$266K 0.04%
5,052
+170
+3% +$8.88K
NTLA icon
306
Intellia Therapeutics
NTLA
$1.49B
$255K 0.03%
6,263
+454
+8% +$18.4K
UNH icon
307
UnitedHealth
UNH
$376B
$249K 0.03%
518
PCRX icon
308
Pacira BioSciences
PCRX
$1.04B
$249K 0.03%
6,204
+158
+3% +$6.53K
CHWY icon
309
Chewy
CHWY
$9.25B
$234K 0.03%
5,930
+16
+0.3% +$557
ROL icon
310
Rollins
ROL
$18.3B
$219K 0.03%
+5,123
New +$208K
CHCT
311
Community Healthcare Trust
CHCT
$523M
$218K 0.03%
6,611
+367
+6% +$12.8K
SHOP icon
312
Shopify
SHOP
$152B
$206K 0.03%
+3,187
New +$180K
DOX icon
313
Amdocs
DOX
$5.92B
$202K 0.03%
+2,047
New +$193K
PATH icon
314
UiPath
PATH
$6.61B
$192K 0.03%
+11,577
New +$186K
ITI
315
DELISTED
Iteris, Inc.
ITI
$127K 0.02%
32,019
-4,200
-12% -$18.7K
KNDI
316
Kandi Technologies Group
KNDI
$67.5M
$123K 0.02%
31,088
LCID icon
317
Lucid Motors
LCID
$2.88B
$85.3K 0.01%
+1,238
New +$88.3K
CBAT icon
318
CBAK Energy Technology Ltd
CBAT
$44.3M
$58.3K 0.01%
47,815
-22,636
-32% -$22K
SSKN
319
DELISTED
Strata Skin Sciences
SSKN
$35K ﹤0.01%
3,680
+130
+4% +$1.28K
FABC
320
Fabric.AI Inc
FABC
$16.6M
$8.33K ﹤0.01%
95
AAP icon
321
Advance Auto Parts
AAP
$3.35B
-1,671
Closed -$203K
DNA icon
322
Ginkgo Bioworks
DNA
$528M
-673
Closed -$35.8K
GRPN icon
323
Groupon
GRPN
$1.05B
-10,000
Closed -$42.1K
IEX icon
324
IDEX
IEX
$17B
-6,799
Closed -$1.57M
INTU icon
325
Intuit
INTU
$86.5B
-601
Closed -$268K

Similar funds

Azzad Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Azzad Asset Management held 331 positions worth $744M, up 6.2% from $701M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Azzad Asset Management's Q2 2023 filing shows 14 new, 204 increased, 84 reduced and 11 closed positions. Its largest new stake was GE HealthCare: 25,799 shares worth $2.1M. The largest sale was ABB Ltd, an estimated $4.32M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Azzad Asset Management's largest Q2 2023 buy was GE HealthCare: 25,799 shares worth $2.1M.
  • Azzad Asset Management added most to Public Storage in Q2 2023, an estimated $1.77M increase.
  • Azzad Asset Management's biggest Q2 2023 reduction was Arista Networks, cutting an estimated $2.53M.
  • Azzad Asset Management fully exited ABB Ltd in Q2 2023, selling an estimated $4.32M.
  • Azzad Asset Management's ten largest holdings make up 18% of its $744M portfolio in Q2 2023.
  • Azzad Asset Management opened 14 new positions and closed 11 in Q2 2023.
  • Azzad Asset Management's portfolio value rose 6.2% quarter-over-quarter to $744M.

Based on Azzad Asset Management's 13F filing for Q2 2023, filed 1 Apr 2024.